The significant and growing global prevalence of diabetes continues to challenge people
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …

The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

Diabetes technologies represent a paradigm shift in type 1 diabetes care. Continuous
subcutaneous insulin infusion (CSII) pumps and continuous glucose monitors (CGM) …

The integration of technologies such as continuous glucose monitors, insulin pumps, and
smart pens into diabetes management has the potential to support the transformation of …

Introduction Several different forms of automated insulin delivery systems (AID systems)
have recently been developed and are now licensed for type 1 diabetes (T1D). We …

OBJECTIVE We studied time in tight range (TITR)(70–140 mg/dL) in real-world users of the
MiniMed 780G system (MM780G). RESEARCH DESIGN AND METHODS CareLink …

OBJECTIVE To evaluate change in mean clinic HbA1c from 2014 to 2021 with diabetes
technology use in adults with type 1 diabetes. RESEARCH DESIGN AND METHODS In this …

OBJECTIVE We explored longitudinal changes associated with switching to hybrid closed-
loop (HCL) insulin delivery systems in adults with type 1 diabetes and elevated HbA1c …

Background: We analyzed real-world evidence to assess the performance of the mylife
CamAPS FX hybrid closed-loop system. Methods: Users from 15 countries across different …

Several epidemiological studies have clearly identified diabetes mellitus (DM) as a major
risk factor for cognitive dysfunction, and it is going to be a major public health issue in the …